Navigation Links
VeraLight Announces CE Mark Approval of the SCOUT DS® for Noninvasive Diabetes Screening
Date:7/28/2011

ALBUQUERQUE, N.M., July 28, 2011 /PRNewswire/ -- VeraLight Inc., a privately held medical device company, today announced its SCOUT DS® Device was granted CE Mark approval for noninvasive diabetes screening. The easy to operate device needs no blood, does not require fasting, and yields an immediate result. The patient simply places their forearm onto the portable table-top unit and a quantitative result is reported in about three minutes.

Data from 421 study subjects in the CE filing shows SCOUT DS identified over 60% more people with abnormal glucose tolerance than either the fasting plasma glucose or hemoglobin A1c tests at thresholds established by The World Health Organization. The CE Mark filing was supported by safety and effectiveness studies on a cohort of 738 study subjects. SCOUT DS is Indicated for Use for the noninvasive screening of individuals 18 years or older who are at risk for prediabetes and/or type 2 diabetes to determine whether diagnostic testing is necessary. Prediabetes is defined as impaired glucose tolerance.

"SCOUT DS is an efficient, cost-effective alternative to established blood-based screening methods and we are excited to begin sales in key markets where the need for clinic-based and mass population screenings have been well-recognized by the national health systems and healthcare economists," says VeraLight CEO David Van Avermaete.  

SCOUT DS measures skin fluorescence using proprietary technology to detect biological markers found in skin related to cumulative glycemic exposure, oxidative stress and microvascular changes.   A proprietary algorithm adjusts for variations in skin tone and transforms the measured skin fluorescence and reflectance into a SCOUT Diabetes Score. Over 10,000 patients have been measured on the SCOUT DS during its technology development.

The CE Mark approval is proof of conformity that certifies the product meets European safety, effectiveness, and quality requi
'/>"/>

SOURCE VeraLight Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
2. Boston Scientific Announces $1.0B Share Repurchase Program
3. China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp.
4. Streamline Health Announces Two Clients Have Contracted for Multiple Integrations to Their Epic Systems
5. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
6. West Announces Second Quarter 2011 Results
7. Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress
8. PDL BioPharma Announces Second Quarter 2011 Financial Results
9. BD Announces Agreement to Acquire Carmel Pharma, Inc.
10. Boston Scientific Announces Five-Year, $150 Million Investment in China to Accelerate Commercial Expansion
11. Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Alvarado Hospital unveiled its new facility ... & Joint Institute. The institute is entirely devoted ... surgery and joint replacement. The Spine & Joint ... experience-focused approach. For example, patients are encouraged to ... than patient gowns. "From the ...
(Date:7/29/2015)... LAKE FOREST, Calif. , July 29, ... ) ("Cryoport" or the "Company"), the leading ... the life sciences industry, serving markets including ... organizations, vaccine manufacturers, animal health, and reproductive ... completed the sale of common stock and warrants ...
(Date:7/29/2015)...  Ortho-Clinical Diagnostics, Inc. (OCD) today announced the presentation ... address a range of important tests for clinical labs ... The scientific posters will be delivered during the 2015 ... held July 26 - 30 in Atlanta, ... is emerging stronger than ever since becoming a stand-alone ...
Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3
... DIEGO, Feb. 11, 2011 Conatus Pharmaceuticals Inc. today ... Preferred Stock private placement financing.  This financing was led ... and included participation by existing investors; Aberdare Ventures, Advent ... Roche Venture Fund.  Conatus will use the proceeds to ...
... LOS ANGELES, Feb. 11, 2011 Nationally-acclaimed researcher and ... speech at the 11th National Conference on Cancer Nursing ... potentially deadly infections they were supposed to prevent. ... needleless IV connector devices with silver coated or silver ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Instead of Preventing Infections, Silver Coated Needleless IV Connectors May Actually Cause Them, a Nationally-Recognized Expert Tells National Conference on Cancer Nursing Research 2
(Date:7/30/2015)... ... July 30, 2015 , ... Author Dr. Raul Llanos ... their health in his new self-help book, “ Consciously Healing our Webs of Health, ... a simple message: “If we take responsibility for ourselves, we can create better realities.” ...
(Date:7/30/2015)... ... July 30, 2015 , ... Summer is the dry eye season, especially ... a particularly long, dry and hot 2015 summer season and the dry eye rate ... Sharon Kleyne will discuss the 2015 summer season and identify the primary dry eye ...
(Date:7/30/2015)... Mo (PRWEB) , ... July 30, 2015 , ... ... health and hospice care, announced today that it is hosting a free webinar detailing ... Pierre, RN, BSN, MGA, HEALTHCAREfirst Consultant and former Vice President of Regulatory Affairs for ...
(Date:7/30/2015)... Santa Rosa, CA (PRWEB) , ... July 30, 2015 , ... At the presentation of ... topic of discussion was focused on research presented by the Journal of Arthroplasty ... normal tasks – like driving. , Results of the study confirm what Santa ...
(Date:7/30/2015)... ... July 30, 2015 , ... Diagnotes, Inc. ... reporting for reimbursement from the Centers for Medicare & Medicaid Services (CMS) for ... are experimenting with manual data capture or, in many cases, just deciding it’s ...
Breaking Medicine News(10 mins):Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 2Health News:New book by Dr. Raul Llanos: ‘The power to change is within’ 3Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 2Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 3
... Clinic today reported promising interim results from a Phase ... with recurrent ovarian cancer that is resistant to platinum ... or partial tumor regression from the therapy, which combines ... 2 Consortium (P2C) clinical trial were presented by the ...
... Extend ... to be Changed, SAN DIEGO, Oct. 23 Imagenetix, Inc. (OTC,Bulletin ... of several series of warrants that are scheduled to,expire on October 23, ... $2.00 Warrant holders will have the right to have their warrants ...
... Two carotid stenting,trials examining outcomes in ... that are comparable to guidelines established by ... with carotid artery,surgery. The results of these ... trials session at the Cardiovascular Research,Foundation,s 19th ...
... 23 The Healthcare,Information Technology Standards Panel (HITSP) ... will help to keep patient medical,information secure in ... assure that this information will only be used ... work on an overarching security and privacy architecture ...
... between women,s plasma, rare lung condition, study finds , TUESDAY, ... may not be as dangerous as believed, says a team ... use of plasma from female donors due to the risk ... acute lung injury (TRALI). , Plasma -- the liquid portion ...
... David R. Williams, William G. Allyn Professor of Medical Optics ... Science, has won the 2007 Alfred W. Bressler Prize in ... the Blind. , Williams is being recognized for his extensive ... accepted the award and the $37,500 prize at a ceremony ...
Cached Medicine News:Health News:Mayo Clinic reports possible new therapy for patients with platinum-resistant ovarian cancer 2Health News:Imagentix Offers Extension of Warrants 2Health News:Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery 2Health News:Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery 3Health News:Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery 4Health News:HITSP Defines Overarching Set of Healthcare Security and Privacy Standards 2Health News:Female Blood Donor Concern May Be Unfounded 2Health News:Optical scientist honored for understanding and improving vision 2
Arm Compression Garment...
Long-Sleeve Bolero for targeted compression in the upper arms, upper back and shoulder areas. Plush-shielded hook and eye front closure for comfort and convenient application....
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s...
Sub Pectoral Bra...
Medicine Products: